SI-BONE Inc
NASDAQ:SIBN
SI-BONE Inc
NASDAQ:SIBN
Price:
14.57 USD
2.1%
Market Closed
Updated:
Apr 28, 2024
Section:
Relative Value
The Relative Value of one
SIBN
stock under the Base Case scenario is
21.47
USD.
Compared to the current market price of 14.57 USD,
SI-BONE Inc
is
Undervalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SIBN
Relative Value
Base Case
21.47
USD
Undervaluation 32%
Valuation Multiples
Multiples Across Competitors
SIBN Competitors Multiples
SI-BONE Inc Competitors
SI-BONE Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
SI-BONE Inc
NASDAQ:SIBN
|
592.9m USD | 4.3 | -13.7 | -11.2 | -9.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.6 | 33.1 | 19.5 | 29 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 18.2 | 67 | 54.9 | 68.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.2 | 40.3 | 25.1 | 31.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 7.5 | 68.3 | 31.7 | 47.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.3 | 25.2 | 13.5 | 19.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 3.4 | 54.9 | 18.4 | 38.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 2.7 | 38.9 | 18.6 | 31.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.7 | 37 | 26.8 | 29 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | 88.5 | 59.6 | 77.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 10.2 | 30.8 | 26.7 | 26.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
